Skip to main content

Exterior Artificial Pancreas Project- Crimson Publishers

Exterior Artificial Pancreas Project- Crimson Publishers

Objective: Pump size exterior artificial pancreas that will keep the glucose between 120-150mg/dl.

Method: The whole project based in idea that we should already know one insulin unit how much is able to go down the glucose and one glucagon’s unit how much is able to increase the glucose. Less than 120mg/dl it uses glucagon’s. More than 150mg/dl it uses insulin. The pump checks the glucose automatically every 8 minutes. The pump (which is software decision) will choose between insulin or glucagon’s base in internal database table with prerequisite glucose values and the insulin or glucagon’s units requiring for each glucose value (adaptive database table for each diabetic). The pump (the software) is able to choose how many insulin or glucagon’s units it should use (that is not based on what the diabetic will eat, but base on the current glucose level that received from the sensor which is located in human body, needle and sensor are one piece). The insulin should have work duration 8 minutes and works instantly.

Result: I chose 120mg/dl as the lowest allowance glucose level because this glucose level is secure for the diabetic (there is a time to prevent big hypoglycemia).

Conclusion: This project offers to diabetic’s insulin injections freedom, hypoglycemia prevention, run emergency tests, ideally for all ages, endocrinologists will have the software to adapt the internal database table of the pump for each diabetic needs.

https://crimsonpublishers.com/rmes/fulltext/RMES.000692.php

For more open access journals in crimson publishers Please click on link: https://crimsonpublishers.com

For more articles on Research in Medical & Engineering Sciences Please click on link: https://crimsonpublishers.com/rmes/

Labels:

Comments

Post a Comment

Popular posts from this blog

The Malachite Wen-Myeloid Sarcoma- Crimson Publishers

The Malachite Wen-Myeloid Sarcoma- Crimson Publishers   Contingent to World Health Organization (WHO) classification, myeloid sarcoma is denominated as a tumefaction comprised of myeloblasts amalgamated at an anatomical site divergent from the bone marrow which engenders distortion of normal tissue architecture. Generally, myeloid sarcoma is contemplated to be equivalent to and concurrent with acute myeloid leukaemia (AML), although lesions may occur in isolation. Additionally designated as granulocytic sarcoma, chloroma or extramedullary myeloid tumour, myeloid sarcoma categorically represents as a distinct tumefaction associated with architectural effacement of circumscribing soft tissue. Myeloid sarcoma may emerge as a de novo lesion or manifest as therapy related myeloid neoplasm or as disease progression within myeloproliferative neoplasm (MPN), myelodysplastic syndrome (MDS) or myelodysplastic / myeloproliferative neoplasm (MDS / MPN). In contrast, leukaemia cutis (LC) is...
Post a Comment
Read more

Recent Developments of Decentralized Clinical Trial Technology in Korea- Crimson Publishers

Recent Developments of Decentralized Clinical Trial Technology in Korea- CrimsonPublishers   Clinical trials are routinely performed on human participants to evaluate the safety and effectiveness of new treatments such as drugs and medical devices. Recent advances in Information and Communication Technology (ICT) have led to the development of Decentralized Clinical Trials (DCTs). DCTs allow participants to participate in various types of clinical trials without having to visit hospitals. Data collection and frequent interactions between participants and medical staff can be possible via remote monitoring environments. In addition, the costs and time for clinical trials conduction can be significantly reduced. The development of ICT-based DCT technologies has already initiated. However, the adoption of DCTs was facilitated by the coronavirus disease 2019 (COVID-19) pandemic. Interest in and research on DCTs has also grown in Korea. This study describes the present state of DCT ...
Post a Comment
Read more

Home Remedy for Malnourished Kids Works Wonders Case Report-Crimson Publishers

Home Remedy for Malnourished Kids Works Wonders Case Report- Crimson Publishers Ashish Satav* Head Administration, India *Corresponding author:  Ashish Satav, Head Administration, India, Tel: 91-9423118877; Email: Submission:  July 13, 2018;  Published:  September 10, 2018 Many severely malnourished (grade IV) children continue todie every year in Melghat because their parents are unwilling to hospitalize them. Myths and mis-beliefs too hold them back from approaching the hospital. However, doctors from MAHAN Trustworking in the tribal belt have proved that these children can bealso saved through home or community based treatment, bothmedical and dietary. Successful treatment of Lakshmi SukhramJamunkar, a 23-month-old girl whose condition was worse than agrade IV child, is a shining example. She was treated at her homeunder the supervision of an illiterate but well-trained village healthworker, Meerabai. Lakshmi‘s case s...
Post a Comment
Read more